Form 4 for LIVN LivaNova PLC
Accepted 2026-04-01 17:20:24 ET · period of report 2026-03-30 · accession 0001639691-26-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-01 17:20 | 2026-03-30 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $0.00 | +3,184 | 12.1K | +36% | $0 |
| D | 2026-04-01 17:20 | 2026-03-30 | LIVN | Poletti Franco | Pres, Cardiopulmonary | F - Tax | $61.27 | -1,370 | 10.8K | -11% | -$83.9K |
| DM | 2026-04-01 17:20 | 2026-03-30 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $0.00 | -3,184 | 4,258 | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-30 | M | A | 3,184 | $0.00 | 12,125 | D | — | — | (F1) Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. |
| 2 | Common | Ordinary Shares | 2026-03-30 | F | D | 1,370 | $61.27 | 10,755 | D | — | — | (F2) Shares withheld to satisfy tax liability. |
| 3 | Derivative | Restricted Stock Units | 2026-03-30 | M | D | 171 | $0.00 | 0 | D | — · — to — | 171 Ordinary Shares | (F3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. (F4) On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. (F4) On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. |
| 4 | Derivative | Restricted Stock Units | 2026-03-30 | M | D | 325 | $0.00 | 325 | D | — · — to — | 325 Ordinary Shares | (F3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. (F5) On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. (F5) On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. |
| 5 | Derivative | Restricted Stock Units | 2026-03-30 | M | D | 558 | $0.00 | 1,117 | D | — · — to — | 558 Ordinary Shares | (F3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. (F6) On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. (F6) On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 6 | Derivative | Restricted Stock Units | 2026-03-30 | M | D | 2,130 | $0.00 | 4,258 | D | — · — to — | 2,130 Ordinary Shares | (F3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. (F7) On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement. (F7) On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement. |